The Japan-based company said that the clearance of the Vantage Orian “represents a new standard in the premium wide bore 1.5T market,” and touted that the device includes new technology intended to improve productivity, patient comfort and diagnostic clinical confidence.
“We are committed to offering our customers the premium diagnostic imaging tools they need to deliver accurate, confident and effective patient care. The Vantage Orian was designed to increase productivity while ensuring patient comfort and delivering uncompromised clinical confidence,” CT, PET/CT and MR biz units senior director Dominic Smith said in a press release.
In April, Canon Medical Systems said that it won FDA clearance for its Aquilion Precision ultra-high resolution computed tomography system.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.